Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.
The participation of Dr. Renslow Sherer in this
Forum is made possible in part by an unrestricted educational grant
from Abbott Laboratories.
|
|
 |
|
Resistance to PI's
Dec 31, 2004
Diagnosed + in November 2002 with a virus resistant to PI's (though I don't know to what extent; I guess that I should ask).
I'm treatment-naive and will likely go on meds soon as my CD4 is around 280 and VL is about 5,000. My doctor said my first regimen would be combivir and sustiva.
Does resistance to PI's significantly impact my long-term prognosis? I just learned today that my resistance was to PI's, which are credited to extending so many lives since their development in the '90s. (I knew that I had some resistance previously but was unaware of to what class of drugs.)
Is it worse to be resistant to PI's than other classes of drugs? This news really scared me.
Thank you for your response. This site is an amazing resource!
|
 |
|
 |
|
Response from Dr. Sherer
There is evidence that the response to an ART regimen may be compromised in a patient who acquires resistance mutations, but the answer in your case may hinge on the exact mutations that were found. As you suggest, it will be useful to understand exactly which mutations your virus has, and how these mutations might impact your response to therapy.
The choice of an NNRTI + NRTIs for the first regimen makes sense in these circumstances.
Note that within the PI class, there are many options that provide strong antiviral activity, even in patients with a few baseline PI mutations. For example, lopinavir/r (Kaletra) is not compromised in its effectiveness by the presence of 1-3 PI mutations, and significant reduction in potency does not occur until there are 6-8 PI genotypic mutations.
I suggest that you ask these questions of your doctor, and share this response with him or her, as you consider what your options are for the time when, if at all, you need therapy with a PI.
|
|
|
 Please remember that this forum is designed for educational purposes only, and experts are not engaged through this
forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible
for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.
Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this
forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or
edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their
messages.
Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as
legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a
health or legal problem, you should consult your own health care provider or your attorney.
Copyright notice.
|
|
|
|
